Scientific References

Read more about our targets and our scientific approach.

May 2026

A Phase 1/2 First-in-Human Study of TH9619 ​in Patients With Advanced Refractory Solid Tumours (ODIN)

Moreno et al.

Read more

April 2023

Alanna C. Green, Petra Marttila et al.
Nature Metabolism

May 2022

Thomas Helleday and Sean G Rudd
Molecular Oncology

April 2020

Zhiyuan Zhu and Gilberto Ka Kit Leung, Scientific Reports

April 2020

More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?

Zhiyuan Zhu and Gilberto Ka Kit Leung

June 2019

Sara Sdelci, André F Rendeiro et al.
Nature Genetics

February 2017

Robert Gustafsson, Ann-Sofie Jemth et al.
Cancer Research

October 2015

Nina Gustafsson Sheppard, Lisa Jarl et al.
Scientific Reports

Latest news